Paysign, Inc. (PAYS) Stock Price & Analysis
Paysign, Inc. (PAYS) closed at USD 13.97 on Wednesday, October 28, 2026, down 3.92% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 14.54; the Oct 28, 2026 session ranged USD 13.57–14.57 on volume of 1,177,969 shares. Market capitalization is $788.78M, with a 52-week range of USD 3.08–16.15 (NCM). Source: Nexqual, retrieved October 29, 2026 at 13:20 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PAYS.md
Key facts (PAYS)
- Last four reported quarters (through Jun 30, 2026): revenue $101M, net income $15.8M (15.7% margin), free cash flow $73.5M (SEC filings).
- Valuation: P/E 50.0x (avg 36.1x at the last 3 fiscal year-ends), EV/EBITDA 23.3x, net cash $171M.
- Analysts: Buy (mean 1.60 on a 1–5 scale) (5 analysts), mean target USD 14.1 (range 11.5–15).
- Total return with dividends: 1Y +156.8% vs S&P 500 +13.6%; 5Y +454.4% vs S&P 500 +79.8%.
- Next earnings: 2026-11-09, EPS estimate USD 0.13, revenue estimate $29.0M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (PAYS)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $29.5M | $38.0M | $47.3M | $58.4M | $82.0M | $101M |
| Gross profit | $14.7M | $21.0M | $24.1M | $32.2M | $48.7M | — |
| Operating income | -$2.7M | $344K | -$167K | $1.0M | $7.4M | $17.1M |
| Net income | -$2.7M | $1.0M | $6.5M | $3.8M | $7.6M | $15.8M |
| EPS (diluted) | -$0.05 | $0.02 | $0.12 | $0.07 | $0.13 | — |
| Free cash flow | $14.9M | $25.2M | $27.4M | $22.5M | $51.2M | $73.5M |
| Gross margin | 49.9% | 55.1% | 51.1% | 55.1% | 59.4% | — |
| Operating margin | -9.3% | 0.9% | -0.4% | 1.7% | 9.0% | 17.0% |
| Net margin | -9.2% | 2.7% | 13.7% | 6.5% | 9.2% | 15.7% |
| Revenue growth | +22.2% | +29.1% | +24.3% | +23.5% | +40.5% | — |
| Cash + short-term investments | $7.4M | $89.9M | $109M | $122M | $165M | — |
| Total debt | — | — | — | $0K | $8.0M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (PAYS)
P/E 50.0x · P/S 7.8x · EV/EBITDA 23.3x · EV/Sales 6.1x · P/FCF 10.7x · P/B 13.1x · FCF yield 9.32% · Earnings yield 2.00% · Buyback yield (TTM) 0.00% · Net cash $171M · EV $618M
P/E at fiscal year-ends: Dec 2025 40.7x, Dec 2024 44.0x, Dec 2023 23.5x.
Analysts (PAYS)
Consensus Buy (mean 1.60 on a 1–5 scale), 5 analysts; mean target USD 14.1 (low 11.5, high 15).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-30 | DA Davidson | Target raised | Buy | $12 → $15 |
| 2026-09-15 | Lake Street | Target raised | Buy | $13 → $15 |
| 2026-08-06 | DA Davidson | Target raised | Buy | $9 → $12 |
Total return (dividends reinvested) (PAYS)
| 1Y (from 2025-10-29) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +156.8% | +454.4% |
| S&P 500 (SPY) | +13.6% | +79.8% |
| Per year | +157.6% | +40.8% |
| Volatility (annualized) | 65.6% | 68.3% |
| Max drawdown | -42.4% (Dec 2025→Mar 2026) | -63.4% (Jul 2024→Mar 2025) |
PAYS earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| Aug 5, 2026 | Quarter ended Jun 30, 2026 | $0.10 | $0.08 | Beat +25.0% | +33.6% |
| May 12, 2026 | Quarter ended Mar 31, 2026 | — | — | — | -13.0% |
| Mar 24, 2026 | Quarter ended Dec 31, 2025 | $0.02 | $0.03 | Miss −$0.01 | +54.2% |
| Nov 12, 2025 | Quarter ended Sep 30, 2025 | $0.04 | $0.04 | In line | +6.0% |
| Aug 5, 2025 | — | — | — | — | -27.1% |
| May 8, 2025 | — | — | — | — | +18.0% |
| Mar 25, 2025 | — | — | — | — | -9.9% |
| Nov 5, 2024 | — | — | — | — | +10.9% |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
PAYS recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Aug 6, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
| Aug 5, 2026 | 8-K | Quarterly results |
| Jul 29, 2026 | Schedule 13G | BlackRock, Inc.: 5.4% of shares, passive 5%+ holder |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
PAYS company outlook (results filed Aug 5, 2026)
- “Raising full-year 2026 outlook – revenue $114.0 million to $117.0 million;”
Quoted word-for-word from the SEC 8-K results press release.
PAYS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.13 | $0.07 | +77.3% | $29.0M | 2 |
| Next quarter (ends Dec 2026) | $0.09 | $0.06 | +58.8% | $29.3M | 2 |
| Current fiscal year (ends Dec 2026) | $0.49 | $0.33 | +48.5% | $114.7M | 2 |
| Next fiscal year (ends Dec 2027) | $0.61 | $0.44 | +40.8% | $133.7M | 2 |
PAYS options: expected move
Options price a move of about ±21.2% (±$2.90) by Nov 20, 2026, which includes earnings on Nov 9, 2026. Over the last 8 reports the stock moved ±21.6% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 22 | 97.0% | ±21.2% |
| Dec 18, 2026 | 50 | 75.3% | ±23.5% |
| Mar 19, 2027 | 141 | 70.4% | ±35.4% |
| Jun 17, 2027 | 231 | 71.4% | ±45.1% |
30-day implied volatility 80.9% vs 48.6% realized over the last 30 trading days. Put/call ratio (volume) 0.01. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 29, 2026 at 13:20 UTC)
| Price | USD 13.97 |
|---|---|
| Change | ▼ 3.92% (down) |
| Previous Close | USD 14.54 |
| Open | USD 14.5 |
| Day Range | USD 13.57 – 14.57 |
| 52-Week Range | USD 3.08 – 16.15 |
| Volume | 1,177,969 shares |
| Market Cap | $788.78M |
| Exchange | NCM |
Technical Analysis (PAYS)
Nexqual's technical model rates PAYS "BUY" based on 4 bullish and 2 bearish signals across 127 daily candles, as of October 29, 2026 at 13:20 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 45.24 (neutral) |
| vs SMA50 | Above (USD 13.75) |
| MACD | 0.31 (positive) |
Analyst Ratings (PAYS)
Wall Street analysts rate PAYS "Buy" based on 5 analysts, with a mean price target of USD 14.1 (range USD 11.5–15), per Nexqual as of October 29, 2026 at 13:20 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 14.1 |
| High Target | USD 15 |
| Low Target | USD 11.5 |
| Buy / Hold / Sell | 5 / 0 / 0 |
Earnings (PAYS)
| Next Earnings Date | 2026-11-09 |
|---|---|
| EPS Estimate | USD 0.13 |
| Revenue Estimate | $29.02M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.1 vs est 0.08 ▲ beat |
| 2025-12-31 | USD 0.02 vs est 0.03 ▼ miss |
| 2025-09-30 | USD 0.04 vs est 0.04 ▲ beat |
Source: Nexqual, October 29, 2026 at 13:20 UTC.
Financials & Fundamentals (PAYS)
| Total Revenue | $100.64M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +48.10% |
| Gross Margin | +60.99% |
| Operating Margin | +28.34% |
| Profit Margin | +15.67% |
| ROE | +30.82% |
| Debt / Equity | 0.09 |
| Current Ratio | 1.14 |
| Total Cash | $27.37M |
| Total Debt | $5.71M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $73.51M (73.0% of revenue) |
Source: Nexqual, October 29, 2026 at 13:20 UTC.
Financial Health Score (PAYS)
Nexqual rates Paysign, Inc.'s overall financial health "Strong" across five dimensions, as of October 29, 2026 at 13:20 UTC.
| Growth | Strong — Revenue +40% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 61%, operating 17% (last 4 quarters to Jun 2026, SEC) |
| Balance Sheet | Strong — $176M cash and investments vs $5M debt (Jun 2026, SEC), net cash |
| Cash Flow | Strong — FCF $74M (last 4 quarters to Jun 2026, SEC), 73% margin |
| Efficiency | Strong — ROE 26%, ROA 5.0% (last 4 quarters, SEC) |
Ownership (PAYS)
| Insider Ownership | +21.00% |
|---|---|
| Institutional Ownership | +54.96% |
| Shares Outstanding | 56.46M |
| Float | 33.87M |
| Short % of Float | +5.63% |
Source: Nexqual, October 29, 2026 at 13:20 UTC.
Leadership (PAYS)
Paysign, Inc. is led by Mark R. Newcomer, Co-Founder, President, CEO & Director, per Nexqual as of October 29, 2026 at 13:20 UTC.
| Co-Founder, President, CEO & Director | Mark R. Newcomer |
|---|---|
| President of Patient Affordability | Matthew Turner |
| CFO & Treasurer | Jeffery B. Baker |
| Chief Operating Officer | Cosimo Cambi |
| Chief Technology Officer | Brad Cunningham |
Major Backers & Investors (PAYS)
Notable institutional backers of Paysign, Inc. include Topline Capital Management, LLC, Punch & Associates Investment Management, Inc., Thompson, Siegel & Walmsley LLC, according to Nexqual as of October 29, 2026 at 13:20 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Topline Capital Management, LLC | 8.22% |
| Punch & Associates Investment Management, Inc. | 3.67% |
| Thompson, Siegel & Walmsley LLC | 2.5% |
| Renaissance Technologies | 1.9% |
| Palisades Investment Partners, LLC | 1.77% |
| Arrowstreet Capital, Limited Partnership | 1.6% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 5.45% |
| Vanguard Group | 2.83% |
| Geode Capital | 1.85% |
| State Street | 1.49% |
Source: Nexqual, October 29, 2026 at 13:20 UTC.
From Paysign, Inc.'s Latest SEC 10-K Filing (filed 2026-03-25)
Key Strengths & Strategy (as disclosed to the SEC)
- We are a vertically integrated provider of prepaid card products and processing services for corporate, consumer and government entities.
- We are a direct processor of these claims and conduct adjudication on an internal proprietary platform specifically designed to address the needs of our clients and their unique business rules.
- Apherion replaces fragmented legacy systems with an integrated platform that enables operators to reduce collection costs, improve donor experience and retention, maintain compliance and scale efficiently across single-center and multi-center donation networks. response to changes in the regulatory environment, have introduced new products similar to a GPR card but that act as true demand deposit accounts accessible with a debit card ("DDA Debit Card").
- We differentiate ourselves with this specific product by offering accelerated adjudication and payments for medical claims relative to our competition.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DLO | DLocal Limited | USD 13.77 | ▼ 1.99% |
| BLSH | Bullish | USD 28.73 | ▼ 0.73% |
| CORZ | Core Scientific, Inc. | USD 15 | ▲ 5.15% |
| RELY | Remitly Global, Inc. | USD 24.27 | ▲ 0.25% |
| TENB | Tenable Holdings, Inc. | USD 48.72 | ▲ 0.14% |
| BB | BlackBerry Limited | USD 9.4 | ▼ 1.57% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 13:20 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt